Nancy Bellei

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK

Merryn Voysey, Sue Ann Costa Clemens, Shabir A. Madhi et al. · The Lancet · 2020 · 5K citations · Full text

Veterinary Medicine, Infectious Diseases, Preventive Medicine +17

Epidemiological and clinical features of human coronavirus infections among different subsets of patients

Tatiane Karen Cabeça, Celso Granato, Nancy Bellei · Influenza and Other Respiratory Viruses · 2013 · 135 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Biology +8

Acute respiratory infection and influenza‐like illness viral etiologies in Brazilian adults

Nancy Bellei, Emerson Carraro, Ana Helena Perosa et al. · Journal of Medical Virology · 2008 · 94 citations · Full text

Veterinary Medicine, Infectious Diseases, Internal Medicine +17

Is Higher Viral Load in SARS-CoV-2 Associated with Death?

Klinger Soares Faíco-Filho, Victor Cabelho Passarelli, Nancy Bellei · American Journal of Tropical Medicine and Hygiene · 2020 · 88 citations · Full text

Life Sciences, Clinical Sciences, Infectious Diseases +13

Nitazoxanide superiority to placebo to treat moderate COVID-19 – A Pilot prove of concept randomized double-blind clinical trial.

Vinicius Fontanesi Blum, Sérgio Cimerman, James Hunter et al. · EClinicalMedicine · 2021 · 75 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +13